Efficacy analysis of tyrosine kinase inhibitors on rare non-small cell lung cancer patients harboring complex EGFR mutations

The efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI) in patients with non-small cell lung cancer (NSCLC) is related to EGFR mutations. Although the p.L858R point mutation in exon 21 and the in-frame deletion mutation in exon 19 are well known, efficacy of EGFR-TKI i...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Liang, Song, Zhi-Gang, Jiao, Shun-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135336/
https://www.ncbi.nlm.nih.gov/pubmed/25130612
http://dx.doi.org/10.1038/srep06104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135336/
https://www.ncbi.nlm.nih.gov/pubmed/25130612
http://dx.doi.org/10.1038/srep06104

Ejemplares similares